IRD vs TER · rev $11.0M vs P/E 76, rev $2.82B
Opus Genetics, Inc. (IRD) versus Teradyne Inc (TER) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
Latest reported TER revenue for 2024-12-31 was $2.82B. Net income was $542.4M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. TER currently screens at market cap $63.96B and trailing P/E 75.7.
IRD currently screens at market cap $35.7M. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Not investment advice. Open the IRD and TER stock pages for the full models.
Not investment advice.